The APLAR 2020 preliminary program is now available!
To view the preliminary program below, please select on the specific day tab that you wish and the individual program will be shown.
The program is still under review and is subject to change.
Pre-Congress program
| Friday 23 October | ||||
| 1400-1700 | Pre-Congress workshop CH 1 Biomechanics & Movement Workshop with BJC Health Speakers: Errol Lim Managing Director of BJC Health Dr Irwin Lim Consultant Rheumatologist Sarah Comensoli Exercise Physiologist & Manager of Allied Health services Dr Herman Lau Rheumatologist Robyn Yin Head Exercise Physiologist Belinda Price Physiotherapist Blanche Leung Physiotherapist Heidi Kim Physiotherapist Brought to you by  |
|||
Featured program
| 0945 – 1130 | CH1: Plenary session 1: Opening Ceremony and Management of rheumatic diseases during the COVID-19 pandemic Chairpersons: Tsutomu Takeuchi and Rohini Handa Speakers COVID-19 in rheumatology practice in Japan Tsutomu Takeuchi, Keio University School of Medicine American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic Ted Mikuls, University of Nebraska RMD and COVID19: The EULAR perspective Robert Landewe, University of Amsterdam |
|||
| 1130 – 1245 | CH2: Morning symposium 1 “Beyond remission” based on patients’ subjective experiences for improved RA control Chairpersons: Professor Masayoshi Harigai Professor and Chairperson of Department of rheumatology/Tokyo Women’s Medical University Speakers: Associate Professor Yuko Kaneko Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine | CH3: Morning symposium 2 Solving the patient puzzle: A pragmatic approach to SpA management Speakers: Dr Mitsumasa Kishimoto Associate Professor, Department of Nephrology and Rheumatology/Kyorin University School of Medicine Dr Philip Robinson Associate Professor/Brisbane Rheumatology | CH4: Morning symposium 3 New treatment paradigm in RA: Focusing on a novel JAK inhibitor Chairpersons/Speakers: Professor Tatsuya Atsumi Professor of Medicine in the Faculty of Medicine/Hokkaido University Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | |
Brought to you by  | Brought to you by  | Brought to you by  | ||
| 1245 – 1315 | Break | |||
| 1315 – 1445 | Prospects for JAK inhibitors in the treatment of rheumatoid arthritis Speakers: Dr Kei Ikeda Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital Dr Akio Morinobu Department of Rheumatology/Kyoto University Graduate School of Medicine | Basic and Clinical of Rheumatology Chairpersons: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School Speakers: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health |
||
Brought to you by | Brought to you by |
|||
| 1445 – 1500 | Break | |||
| 1500 – 1640 | CH1: SpA – 1: New advances in Axial Spondyloarthritis | CH2: SLE – 1: Progress and perspectives on SLE in the APLAR region | CH3: Imaging: Imaging in rheumatic diseases – where do we stand | CH4: Treating children with rheumatic diseases in Asia Pacific: The Great Divide |
| Chairpersons: Mitsumasa Kishimoto, Katy Leung, Nazrul Islam | Chairpersons: Sandra Navarro and Yoshiya Tanaka | Chairpersons: Chi-Chen Chang and Ved Chaturvedi | Chairpersons: Sumaira Farman and Surjit Singh |
|
| Outcome of Juvenile spondyloarthropathy in adulthood Amita Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences | Patient education as vital to improving outcomes Laniyati Hamijoyo, University of Padjadjaran | Ultrasound and its clinical use in rheumatoid arthritis Kei Ikeda, Chiba University Hospital | Asia-Pacific Pediatric Rheumatology: Where Do We Stand Sumaira Farman, National Hospital & Medical Center; Al-Aleem Medical College; Fatima Jinnah Medical University |
|
| Improving Access to Care in Resource Challenged Settings: Lessons from the Paediatric Task Force Global MSK Health Helen Foster, Newcastle University |
||||
| Treat-to-Target in SpA, how far are we going? James Wei, Chung Shan Medical University Hospital | Progress and Perspectives on SLE in the APLAR region Evan Vista, St. Luke’s Medical Center and College of Medicine | Ultrasound in large vessel vasculitis Kuo-Lung Lai, Taichung Veterans General Hospital | JIA: Geographic variability in treatment and long-term outcomes of JIA Soamarat Vilaiyuk, Mahidol University |
|
| When and how to use, or not to use MRI in SpA” Ashish Jacob Mathew, Christian Medical College | Interim report of the APLAR consensus statements on the management of SLE Chi Chiu Mok, Tuen Mun Hospital | MRI in Rheumatoid Arthritis Mami Tamai, Nagasaki University | Macrophage Activation Syndrome: Analysis of various Cytokines Masaki Shimizu, Tokyo Medcial And Dental University |
|
| Novel assessment tool for bony damage in spondyloarthritis Lai-shan Tam, The Chinese University of Hong Kong | Updates on the Asia Pacific Lupus Collaboration (APLC) cohort Eric Morand | Ultrasound and its clinical use in spondyloarthropathy Lee Ka Wing Gavin | Autoinflammatory disorders: Spectrum seen in Asia Pacific Sulaiman Al-Mayouf, King Faisal Specialist Hospital & Research Center |
|
| Vasculitis: Childhood onset Takayasu arteritis: an update Satish Kumar, Christian Medical College |
||||
| Panel Q&A | Panel Q&A | Panel Q&A | Panel Q&A | |
| 1640 – 1740 | CH1: Abstract session: IgG4-RD, AOSD/sJIA, Kawasaki disease | CH2: Abstract session: SLE and APL syndrome 1 | CH3: Abstract session: IIM, SSc, SjS | CH4: Abstract session: COVID-19 and CTD |
| Chairperson: TBA | Chairperson: Sandra Navarro | Chairperson: Yeong-Wook Song | Chairperson: Rohini Handa |
|
| Increased Human Neutrophil Lipocalin and its Clinical Relevance in Adult-Onset Still’s Disease Ji Li, Peking University International Hospital | Platelet Indices Could Be Simple, Reliable Predictors of Thrombotic Events in Patients with Antiphospholipid Syndrome Yu Shi, Peking Union Medical College | Clinical and swallowing outcomes in patients with dermatomyositis and polymyositis with dysphagia using the Food Intake LEVEL Scale Shin-ichiro Ohmura, Seirei Hamamatsu General Hospital | Rheumatic diseases on COVID-19 era Selma Abdellaoui, Beni Messous Hospital |
|
| Different Immunophenotypes Characterized IgG4-Related Disease Clinical Phenotypes Eduardo Martín-Nares, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán | SLE Disease Activity Score (SLE-DAS) is a comparable disease activity measure to SLEDAI-2K Masanori Kono, University of Tokyo Hospital | Immunomodulatory Therapy: a New Strategy for Dermatomyositis /Polymyositis Shengxiao Zhang, The Second Hospital of Shanxi Medical University | Prevalence of emotional disorder and sleep quality in patients with systemic lupus erythematosus during COVID-19 epidemic: a cross-sectional study Jing Zhu, Sichuan Provincial People’s Hospital |
|
| Abnormality of peripheral lymphocyte subsets in patients with Bechet’s disease and their restorations after receiving new immunomodulatory therapy Shengxiao Zhang, The Second Hospital of Shanxi Medical University | Development of a genetic risk score for Filipino patients with systemic lupus erythematosus Michael Tee, University of The Philippines | Characteristics And Outcomes Of Overlap Myositis: A Comparative Multigroup Study In Adults And Children with Idiopathic Inflammatory Myopathies (IIM) Naveen R, Sanjay Gandhi Post Graduate Institute Of Medical Sciences | Factors associated with use of telemedicine for follow-up of lupus nepthritis in the COVID-19 outbreak Ho So, The Chinese University of Hong Kong |
|
| Application Of Preliminary PRINTO Classification Criteria For SJIA In An Indian Cohort Devang Pandya, Dev Children’s Hospital | The Association between Serum Leptin Levels, Body Mass Index, and Disease Activity in Women with Systemic Lupus Erythematosus Nittayawadee Aeamsaard, Phramongkutklao Hospital and College of Medicine | Prognosis and Treatments of Patients with Myositis-associated Severe Interstitial Lung Disease: A Descriptive Study using National Inpatient Database in Japan Hiroki Furuya, Chiba University Hospital | Spectrum Of Systemic Inflammatory Syndrome In Children During COVID 19 Pandemic In India Devang Pandya, Dev Children’s Hospital |
|
| Long-term outcome of 21 cases of giant coronary aneurysm after Kawasaki disease – Our 40 years’ experience Tomomi Sato, Shiga University of Medical Science | Joint Q&A | Nailfold Capillary Changes in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Tomohiro Sugimoto, Hiroshima University Hospital | Reactive arthritis after COVID-19 infection Keisuke Ono, Kyorin University School of Medicine |
|
| Immunophenotypic analysis of peripheral blood mononuclear cells in IgG4-Related Disease Aya Nishiwaki, The University of Tokyo | Is Rituximab an Adequate Glucocorticoid-Sparing Agent in Idiopathic Inflammatory Myopathies? Bugra Han Egeli | A Healthy Dose of Skepticism: Eosinophilic Granulomatosis with Polyangiitis Initially Presenting as Possible COVID-19 Vincent Anthony Tang, University Of The Philippines – Philippine General Hospital |
||
| Joint Q&A | Joint Q&A | Assessing the Impact on Heath Seeking Behavior During COVID-19 Outbreak in a Group of Rheumatology Patients from Sri Lanka Sunith Atukorale, Ministry of Health |
||
| Joint Q&A | ||||
| 1740 – 1840 | CH1: Evening symposium 1 Management of RA in 2020: is remission achievable and where do JAKs fit? Speakers: Professor Gerd-Rüdiger Burmester Medicine Director of the department of Rheumatology Associate Professor Peter Nash Department of Medicine/University of Queensland, Brisbane, AUSTRALIA | CH2: Evening symposium 2 Treat-to-target in SLE: addressing short- and long-term treatment goals Chariperson: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Speakers: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Professor Ian Bruce National Institute of Health Research (NIHR) Senior Investigator and Professor of Rheumatology/University of Manchester Professor Nancy Agmon-Levin Consultant/Tel Aviv and Chaim Sheba Medical Center | CH3: Evening symposium 3 ILD in Focus: Time to prioritize the lung in CTDs Chairperson: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School Speakers: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School Professor Yannick Allanore Professor of Rheumatology/University of Paris Professor Marco Matucci-Cerinic Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence | CH4: Evening symposium 4 Perspectives around the accumulated evidence for IL-6 in autoimmune disease Chairpersons/Speakers: Dr Kunihiro Yamaoka Division of Rheumatology, Kitasato University Hospital, Japan Dr Shinsuke Yasuda Tokyo Medical and Dental University, Department of Rheumatology, Japan |
| Brought to you by | Brought to you by  | Brought to you by  | Brought to you by  |
|
| 1000 – 1130 | CH1: Plenary session 2: Past, present and future of rheumatology Chairpersons: Syed Atiqul Haq and Yoshiya Tanaka Speakers: Rheumatology: A Crystal Gaze? – a future perspective Syed Atiqul Haq, BSM Medical University Two decades of progress in rheumatology – what have we learnt? Iain McInnes, University of Glasgow |
|||
| 1130 – 1245 | CH2: Morning symposium 5 Treatment of Rheumatoid Arthritis: Past and Future Speakers: Masaru Kato Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University | CH3: Morning symposium 6 To continue, taper or discontinue biologics – Implications on RA treatment outcomes Chairpersons: Professor Yoshiya Tanaka University of Occupational and Environmental Health, Kitakyushu, JAPAN Speakers: Associate Professor Peter Nash Department of Medicine / University of Queensland, Brisbane, AUSTRALIA Associate Professor Khoa Dinh Nguyen Cho Ray Hospital, Ho Chi Minh City, VIETNAM Professor Wen-Chan Tsai Kaohsiung Medical University Hospital, Kaohsiung, TAIWAN | CH4: Morning symposium 7 Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies Chairpersons: Professor Tatsuya Atsumi Professor of Medicine in the Faculty of Medicine / Hokkaido University Speakers: Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | |
Brought to you by  | Brought to you by | Brought to you by | ||
| 1245 – 1315 | Break | |||
| 1315 – 1445 | New insights for clinical practice in Spondyloarthritis, SpA Chairpersons: Associate Professor Yuko Kaneko Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine Professor Naoto Tamura Professor and Chairman, Department of Internal Medicine and Rheumatology/Juntendo University School of Medicine Speakers: Dr Kei Ikeda Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital Dr Kenta Misaki Chief Director, Department of Rheumatology/Kita-Harima Medical Center Professor Yuho Kadono Chief Administrator, Orthopedic Surgery/Saitama Medical University Brought to you by  | Innovative therapeutic alternatives for RA, PsA, AS and nr-axSpA: Individualising the treatment approach Chairperson: Dr Kunihiro Yamaoka Division of Rheumatology, Kitasato University Hospital, Japan Speakers: Dr Kunihiro Yamaoka Division of Rheumatology, Kitasato University Hospital, Japan Professor Lars Erik Kristensen Parker Institute / University Copenhagen Professor Andrew Ostör Cabrini Medical Centre / Emeritus Research Brought to you by  |
||
| 1445 – 1500 | Break | |||
| 1500 – 1640 | CH1: Merge of Basic and Clinical research in Vascultic disorders | CH2: SLE – 2: SLE clinical | CH3: Genetics: recent progress in genetics of rheumatic diseases | CH4: SpA – 2: Updates in PsA |
| Chairpersons: Debashish Danda, Xinping Tian and Masayoshi Harigai | Chairpersons: Yoshiya Tanaka | Chairpersons: Michael Tee and Zhanghou Li | Chairpersons: Atimichi Morita and James Wei |
|
| Section 1: Update on vasculitis | ||||
| Recent advances in AAV Tony Sammel, Prince of Wales and Sydney Eye Hospitals | Management of systemic lupus erythematosus (SLE) during and beyond the COVID-19 pandemic Sandra V. Navarra, University of Santo Tomas | GWAS, eQTL and epigenome of rheumatic diseases Kazuhiko Yamamoto, RIKEN Center for Integrative Medical Sciences | Differential diagnosis of Psoriatic arthritis in daily practice Mitsumasa Kishimoto, Kyorin University School of Medicine |
|
| Behcet’s disease – what is new? Thurayya Arayssi, Weill Cornell Medicine |
||||
| Genetic analysis of Takayasu arteritis Ruchika Goel, Christian Medical College |
||||
| Panel Q&A | Continuing challenges in lupus nephritis Daniel TM Chan, University of Hong Kong | Genetics of Kawasaki Disease: where are we in circa 2020 Surjit Singh, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education And Research, Chandigarh | Risk assessment and prevention of cardiovascular co-morbidities in psoriatic arthritis Lai-Shan Tam, The Chinese University of Hong Kong |
|
| Section 2: APLAR Vascuilitis clinic – recent trends | ||||
| Evaluation of large vessel vasculitis Takahiko Sugihara, Tokyo Medical and Dental University |
||||
| New trials with repurposed drugs in Takayasu arteritis Xinping Tian, Peking Union Medical College Hospital |
||||
| GCA and PMR in Australia: evolving treatment paradigms and clinical research David Liew, Austin Health | Special issues on pregnancy and lactation Aisha Lateef, Woodlands Health Campus | Genetic risk score Sarah Reid | Biomarker for PsA – myth or reality Katy Leung, Singapore General Hospital, Duke-nus Medical School |
|
| Current key areas in futuristic ‘state of the art’ vasculitis research Masayoshi Harigai, Tokyo Women’s Medical University | Treatment update of PsA Peter Nash, Griffith University |
|||
| Panel Q&A | ||||
| SECTION 3: Beginners research on vasculitic diseases | ||||
| Panel discussion by young researchers Carotid Doppler in Takayasu Arteritis Kyaw Thura Zaw GCA research in Adelaide Jem Ninan Suggestions on research in resource limited set up Debashish Danda | Panel Q&A | Panel Q&A | Panel Q&A | |
| 1640 – 1740 | CH1: Abstract session: IIM, SSc, SjS | CH2: Abstract session: SLE and APL syndrome 2 | CH3: Abstract session: OA and Crystal induced arthritis | CH4: Abstract session: SpA, AS-1 |
| Chairperson: Layla Kazkaz | Chairperson: Yoshiya Tanaka | Chairperson: TBA | Chairperson: Mitsumasa Kishimoto |
|
| Clinical Responses to Low-dose Interleukin-2 in Idiopathic Inflammatory Myopathies Miao Miao, Peking University People’s Hospital | Leukocyte immunoglobulin-like receptor A3 (LILRA3) promotes lupus-like disease severity Yundi Tang, Peking University People’s Hospital | The numeral changes of peripheral lymphocyte subsets in 238 patients with GOUT and their correlation analysis with disease activity Lijun Zhao, The Second Hospital of Shanxi Medical University | Efficacy and Safety of Brodalumab, Anti-IL-17 Receptor A Monoclonal Antibody, for Axial Spondyloarthritis, A 68-Week Result of Phase 3 Study James Wei |
|
| Prediction of myocardial abnormalities in systemic sclerosis, assessed in cardiac magnetic resonance imaging, by using artificial neural networks models Masaki Haraoka, St. Marianna University School of Medicine | Should ophthalmologic evaluation be done as a screening test for new onset lupus patients with no eye complaint? Seyedeh Tahereh Faezi, Tehran University of Medical Sciences | Subtype Genome-Wide Meta-Analyses of Clinically-Defined Gout Revealed Multiple Subtype-Specific Gout Loci and Enrichment of Selection Pressure on ABCG2 and ALDH2 Yusuke Kawamura, National Defense Medical College | Improvements in Patient-Reported Outcomes in AS Patients Treated With Golimumab: Sub-Analysis of Asian Patients Enrolled in Phase III Clinical Trials Wen-Chan Tsai, Kaohsiung Medical University |
|
| Clinical analysis of dermatomyositis / polymyositis / cancer-associated myositis and related research on peripheral blood CD4 + T lymphocyte subsets Pan-di Zhang, The Second Hospital of Shanxi Medical University | Long-term Remission in Systemic Lupus Erythematosus Alireza Khabbazi, Connective Tissue Diseases Research Center | Systematic Review and Meta-Analysis of the Prevalence of Neuropathic-Like Pain and Pain Sensitisation in People With Knee and Hip Osteoarthritis Luigi Zolio, Alfred Health | Abnormality of peripheral lymphocyte subsets in patients with ankylosing spondylitis and restoration after receiving immunoregulatory combination therapies Shengxiao Zhang, The Second Hospital of Shanxi Medical University |
|
| Diagnostic Accuracy of Salivary Free Light Chain and Immunoglobulin Assays in Primary Sjögren’s Syndrome Pulukool Sandhya, St Stephens Hospital Delhi | Voclosporin Has Demonstrated Efficacy in Asian Patients With Lupus Nephritis Tatsuya Atsumi, Hokkaido University | A Randomised Placebo-controlled Clinical Trial of Curcuma Longa Extract for Treating Symptoms and Effusion-synovitis of Knee Osteoarthritis (CurKOA trial) Benny Samuel Eathakkattu Antony, University of Tasmania | Comorbidity Profiles among patients with Axial Spondyloarthritis Fariz Yahya |
|
| The Artificial Intelligence for the Prediction of Focal Score of Labial Salivary Gland Biopsy in the Diagnosis of Sjogren Syndrome Noboru Kitamura, Nihon University School of Medicine | Newly Diagnosed Lupus Nephritis in Elderly Predicts Good Renal Outcome: a Distinct Disease Subset from Young-onset Lupus Nephritis Kazuoto Hiramoto, Keio University School of Medicine | The Trajectory of Exercise Adherence Over Time and the Effect of Theory-lead Intervention for Knee Osteoarthritis in Elderly Limin Wang, Peking University | Response to Certolizumab Pegol in Patients with Non-Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Cut-Offs: Post-Hoc Analysis from C-axSpAnd Philip Robinson, University of Queensland |
|
| Effects of Nintedanib in Asian Patients with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD): Subgroup Analysis of the SENSCIS Trial Masataka Kuwana, Nippon Medical School | Thrombotic risk assessment in patient with systemic lupus erythematosus: validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients Wanitcha Chanloung, Chiang Mai University | The Prevalence and Incidence of Symptom Knee Osteoarthritis in the Middle-aged and Elderly: a National Survey from China Limin Wang, Peking University | Imbalance of Th17/Treg In Cardiovascular Diseases of Patients With Ankylosing Spondylitis Tingting Ding, The Second Hospital of Shanxi Medical University |
|
| Joint Q&A | Joint Q&A | Prevalence and Clinical Features of Early-onset Osteoarthritis in a Large Scale Cross-sectional Study Jiajing Peng, Peking University People’s Hospital | Joint Q&A | |
| Joint Q&A | ||||
| 1740 – 1840 | CH1: Evening symposium 5 Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient Chairpersons: Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine Speakers: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine / School of Medicine, University of Occupational and Environmental Health Professor Filip Van den Bosch Professor of Rheumatology and Head-of-Clinic, Department of Rheumatology / University Hospital of Ghent University Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | CH2: Evening symposium 6 Evolution of interleukin-6 inhibiting therapies for rheumatoid arthritis Chairpersons: Dr Yutaka Kawahito M.D., Ph.D. Head of the Department of Inflammation and Immunology/Kyoto Prefectural University of Medicine Speakers: Professor Motomu Hashimoto Department of Advanced Medicine for Rheumatic Diseases, Kyoto University. |
||
Brought to you by  | Brought to you by  |
|||
Text | Text | Text | ||
Test | ||||
TEST |